Concourse Financial Group Securities, Inc. Karyopharm Therapeutics Inc. Transaction History

Concourse Financial Group Securities, Inc.

$1.64 Billion
Q3 2024

Number of Shares

Previous 0 NaN%

Holding current value

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	BUY	$0.7 - $1.06 $0 - $0	0 New	0 $0
Q2 2024 Jul 23, 2024	BUY	$0.87 - $1.58 $0 - $0	0 New	0 $0
Q1 2024 Apr 30, 2024	BUY	$0.72 - $1.66 $0 - $0	0 New	0 $0
Q4 2023 Feb 07, 2024	BUY	$0.68 - $1.31 $0 - $0	0 New	0 $0
Q3 2023 Oct 30, 2023	BUY	$1.14 - $1.81 $0 - $0	0 New	0 $0
Q3 2023 Oct 25, 2023	BUY	$1.14 - $1.81 $0 - $0	0 New	0 $0
Q2 2023 Aug 10, 2023	SELL	$1.79 - $4.59 $1 - $4	-1 Closed	0 $0
Q1 2023 May 15, 2023	BUY	$2.84 - $3.92 $2 - $3	1 New	1 $0
Q4 2022 Jan 30, 2023	BUY	$2.48 - $5.93 $0 - $0	0 New	0 $0
Q3 2022 Nov 15, 2022	BUY	$4.08 - $5.82 $0 - $0	0 New	0 $0
Q2 2022 Aug 09, 2022	BUY	$4.15 - $8.37 $0 - $0	0 New	0 $0
Q1 2022 May 09, 2022	BUY	$5.91 - $14.38 $0 - $0	0 New	0 $0
Q4 2021 Feb 07, 2022	BUY	$5.21 - $8.61 $0 - $0	0 New	0 $0
Q3 2021 Nov 09, 2021	BUY	$4.45 - $10.63 $0 - $0	0 New	0 $0
Q2 2021 Aug 13, 2021	BUY	$8.11 - $11.11 $0 - $0	0 New	0 $0
Q1 2021 May 13, 2021	BUY	$9.85 - $17.69 $0 - $0	0 New	0 $0
Q4 2020 Feb 02, 2021	BUY	$14.15 - $17.19 $0 - $0	0 New	0 $0
Q3 2020 Nov 13, 2020	BUY	$14.14 - $19.71 $0 - $0	0 New	0 $0
Q2 2020 Aug 13, 2020	BUY	$16.6 - $25.25 $0 - $0	0 New	0 $0
Q1 2020 May 13, 2020	BUY	$14.38 - $27.72 $0 - $0	0 New	0 $0
Q4 2019 Feb 14, 2020	BUY	$9.23 - $19.67 $0 - $0	0 New	0 $0
Q3 2019 Nov 13, 2019	BUY	$5.66 - $11.85 $0 - $0	0 New	0 $0
Q2 2019 Aug 13, 2019	BUY	$4.32 - $6.43 $0 - $0	0 New	0 $0
Q1 2019 May 15, 2019	BUY	$4.12 - $10.25 $0 - $0	0 New	0 $0
Q4 2018 Feb 14, 2019	BUY	$8.2 - $16.95 $0 - $0	0 New	0 $0
Q3 2018 Nov 13, 2018	BUY	$17.03 - $21.18 $0 - $0	0 New	0 $0

Others Institutions Holding KPTI

# of Institutions

Shares Held

57.6M

Call Options Held

258K

Put Options Held

81.2K

Vanguard Group Inc Valley Forge, PA

7.65M
Shares

$5.97 Million
0.0% of portfolio
Eversept Partners, LP New York, NY

5.55M
Shares

$4.33 Million
0.36% of portfolio
Palo Alto Investors LP Palo Alto, CA

5.1M
Shares

$3.98 Million
0.58% of portfolio
Adage Capital Partners Gp, L.L.C. Boston, MA

4.32M
Shares

$3.37 Million
0.01% of portfolio
Black Rock Inc. New York, NY

4.17M
Shares

$3.25 Million
0.0% of portfolio

View Full List

About Karyopharm Therapeutics Inc.

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $62.2M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

More about KPTI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account